“On a scale of one to 10, how much pain are you in?” In a recent study published by the Journal of Pain, co-authored by Elizabeth Losin, assistant professor of psychology and director of the Social and Cultural Neuroscience lab at the University of Miami, researchers found that a patient’s…
OCD patients with comorbidities respond well to deep brain stimulation
A new study published in Frontiers in Psychiatry finds that patients with Obsessive Compulsive Disorder (OCD) as well as other psychiatric comorbidities, such as autism spectrum or tic disorders, may respond well to Deep Brain Stimulation (DBS). DBS is a minimally invasive neurosurgical procedure that uses coordinates to target certain…
Surgery is a viable treatment for pancreatic cancer patients especially after chemotherapy
Patients with stage II pancreatic cancer who are treated with chemotherapy followed by resection (an operation that removes the cancerous part of the organ, structure or tissue) live nearly twice as long as patients who receive only chemotherapy, according to a new Journal of the American College of Surgeons study…
To avoid withdrawal symptoms, patients should slowly decrease doses of antipsychotics over months or even years
Withdrawing from antipsychotics may require months or even years, and patients need to gradually reduce to very low doses, according to a new analysis led by UCL and King’s College London academics. The review, published in Schizophrenia Bulletin, is the first-ever scientific paper outlining how exactly antipsychotic medication should be…
Humira (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis
NORTH CHICAGO, Ill., Feb. 24, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Humira (adalimumab) for the treatment of moderately to severely active ulcerative colitis in pediatric patients 5 years of age and older. In clinical trials, Humira induced clinical remission…
CAR T-cell therapy generates lasting remissions in patients with multiple myeloma
In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has generated deep, sustained remissions in patients who had relapsed from several previous therapies, an international clinical trial has found. In a study posted online today by the New England Journal of Medicine, trial leaders report…
New EBRAINS-enabled tool to help guide surgery in drug-resistant epilepsy patients
Scientists of the Human Brain Project have developed a computational tool to locate the areas in a patient’s brain where epilepsy seizures emerge. Now, the team is using EBRAINS to further boost the accuracy with high resolution brain atlas data. With a clinical trial ongoing, the approach aims to give…
New machine learning system developed to identify deteriorating patients in hospital
Researchers in Oxford have developed a machine learning algorithm that could significantly improve clinicians’ ability to identify hospitalized patients whose condition is deteriorating to the extent that they need intensive care. The HAVEN system (Hospital-wide Alerting Via Electronic Noticeboard) was developed as part of a collaboration between the University of…
Sleep disorders: Patients often underestimate their total sleep time
People with sleep disorders commonly have a misperception about their actual sleep behavior. A research group led by Karin Trimmel and Stefan Seidel from MedUni Vienna’s Department of Neurology (Outpatient Clinic for Sleep Disorders and Sleep-Related Disorders) analyzed polysomnography results to identify the types of sleep disorder that are associated…
Effect of Siponimod on Cognition in MS Patients Explored
THURSDAY, Dec. 17, 2020 — Some cognitive tests but not others suggest siponimod may speed cognitive processing in patients with secondary progressive (SP) multiple sclerosis (MS), according to a study published online Dec. 16 in Neurology. Ralph H.B. Benedict, Ph.D., from the University at Buffalo in New York, and colleagues…
Patients with COVID-19 and obesity have poor outcomes not driven by inflammation
Obesity is associated with poor COVID-19 outcomes but a new study suggests this is not due to increased inflammation, but instead may be driven by respiratory issues or other factors. Multiple studies suggest those who are overweight or have obesity are more likely to experience invasive mechanical ventilation, intensive care…